Century Therapeutics, Inc. Common Stock Share Price
NASDAQ: IPSCHealthcare
Live Century Therapeutics, Inc. Common Stock Share Price Chart
O H L
Century Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$1.84Low
$1.84High
Markets Today
| Previous Close | $1.88 |
|---|---|
| Open | $1.84 |
| Volume | 107,407 |
| Day's Range | $1.84 - $1.84 |
| 52W Range | $0.43 - $3.04 |
| Market Cap | $336.80 M |
Historical Performance
| 1M Returns | -4.08 |
|---|---|
| 3M Returns | -17.90 |
| 6M Returns | -18.26 |
| 1Y Returns | +270.81 |
| 5Y Returns | -92.41 |
| 10Y Returns | NA |
Century Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $336.80 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $109.16 M |
| ROE TTM | -0.06 |
| EPS TTM | $-0.90 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.45 |
| EBITDA | $2.60 M |
| Profit Margin | -8.78 |
| Market Cap | $336.80 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $109.16 M |
| ROE TTM | -0.06 |
| EPS TTM | $-0.90 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.45 |
| EBITDA | $2.60 M |
| Profit Margin | -8.78 |
Century Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $109.16 M | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $109.16 M | $0 | $0 | $0 | $0 | $0 |
| Operating Income | $74.18 M | -$34.66 M | -$36.12 M | -$20.65 M | -$23.68 M | -$36.53 M |
| EBITDA | $77.40 M | -$31.46 M | -$26.23 M | -$17.10 M | -$20.68 M | -$22.77 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $3.22 M | $3.20 M | $9.89 M | $3.55 M | $3.00 M | $13.76 M |
| Income Before Tax | $76.56 M | -$32.54 M | -$34.42 M | -$19.24 M | -$21.64 M | -$34.55 M |
| Income Tax Expense | $0 | $0 | $0 | -$68.00 K | $0 | $0 |
| Net Income + | $76.56 M | -$32.54 M | -$34.42 M | -$19.17 M | -$21.64 M | -$34.55 M |
| Net Profit Margin | 70.13% | - | - | - | - | - |
Century Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $9.00 K | $9.00 K | $9.00 K | $9.00 K | $18.00 K | $18.00 K |
| Reserve & Surplus | -$705.47 M | -$738.24 M | -$772.68 M | -$791.89 M | -$814.15 M | -$848.81 M |
| Non-Current Liabilities | $60.67 M | $59.85 M | $46.34 M | $44.54 M | $48.24 M | $39.59 M |
| Current Liabilities | $14.50 M | $14.95 M | $22.03 M | $20.23 M | $13.57 M | $15.07 M |
| Total Liabilities | $75.17 M | $74.79 M | $68.37 M | $64.77 M | $61.81 M | $54.66 M |
| Fixed Assets | $93.73 M | $90.85 M | $87.92 M | $84.23 M | $81.81 M | $68.68 M |
| Current Assets | $169.63 M | $160.17 M | $137.71 M | $120.77 M | $139.04 M | $124.77 M |
| Total Assets | $315.61 M | $284.69 M | $244.72 M | $223.70 M | $326.55 M | $287.01 M |
Century Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $76.56 M | -$32.54 M | -$34.43 M | -$19.17 M | -$21.64 M | -$34.55 M |
| Operating Cash Flow | -$34.62 M | -$27.59 M | -$25.58 M | -$16.08 M | -$25.26 M | -$19.83 M |
| Investing Cash Flow | $27.93 M | $32.54 M | $24.67 M | $22.36 M | -$112.61 M | $17.77 M |
| Financing Cash Flow | $120.00 K | $0 | $0 | $53.00 K | $126.62 M | $311.00 K |
| Change in Cash | -$6.57 M | $4.95 M | -$913.00 K | $6.34 M | -$11.25 M | -$1.76 M |
Century Therapeutics, Inc. Common Stock Return Calculator
The Century Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$739
Invested Amount$10,000
Est. Returns$-9,261
About Century Therapeutics, Inc. Common Stock
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
Popular Stocks
FAQs
What is the share price of Century Therapeutics, Inc. Common Stock today?
Century Therapeutics, Inc. Common Stock (IPSC) share price as of September 18, 2026 is $1.83. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Century Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Century Therapeutics, Inc. Common Stock (IPSC) Share by opening an international trading account with Angel One.
How can I purchase Century Therapeutics, Inc. Common Stock shares in India?
Purchasing Century Therapeutics, Inc. Common Stock (IPSC) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Century Therapeutics, Inc. Common Stock (IPSC) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Century Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Century Therapeutics, Inc. Common Stock (IPSC) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Century Therapeutics, Inc. Common Stock?
The market capitalization of Century Therapeutics, Inc. Common Stock on September 18, 2026, is $336.80 M.
In which sector Century Therapeutics, Inc. Common Stock belongs?
Century Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Century Therapeutics, Inc. Common Stock stocks?
In order to invest in Century Therapeutics, Inc. Common Stock (IPSC) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
